A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TN-C / tenascin-C

[Related PubMed/MEDLINE]
Total Number of Papers: 746
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TN-C  (>> Co-occurring Abbreviation)
Long Form:   tenascin-C
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2022 Cerebral Organoids Maintain the Expression of Neural Stem Cell-Associated Glycoepitopes and Extracellular Matrix. CNS, ECM, LeX, mAb
2022 Diagnostic Value of Aortic Dissection Risk Score, Coagulation Function, and Laboratory Indexes in Acute Aortic Dissection. AAD, ACS, AD, APTT, DD, FDP, FIB, PT, ROC
2022 Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains. CNE-2R, NPC, SMY
2022 Engineering a Mechanoactive Fibrous Substrate with Enhanced Efficiency in Regulating Stem Cell Tenodifferentiation. ADSCs, Col I, PLCL, SCX, SME, TNMD
2022 Ephrin B Activate Src Family Kinases in Fibroblasts Inducing Stromal Remodeling in Prostate Cancer. CAF, Eph, PCa, SFK
2022 Identification of Significant Genes and Pathways Associated with Tenascin-C in Cancer Progression by Bioinformatics Analysis. DEGs, GO, PPI
2022 Influence of the microenvironment dynamics on extracellular matrix evolution under hypoxic ischemic conditions in the myocardium. ECM
2022 Mechanical Compression of Human Airway Epithelial Cells Induces Release of Extracellular Vesicles Containing Tenascin C. EVs, HBE
2022 Mesangial cell-derived tenascin-C contributes to mesangial cell proliferation and matrix protein production in IgA nephropathy. IgAN, MEST score
10  2022 Modulating tenascin-C functions by targeting the MAtrix REgulating MOtif, "MAREMO". FN, TME
11  2022 Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs. ECs, NO, TLR4, TNF, VEGF
12  2022 Serum Tenascin-C and Alarin Levels Are Associated with Cardiovascular Diseases in Type 2 Diabetes Mellitus. AUC, CVD, ELISA, ROC, T2DM
13  2022 Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases Identified That TNC Is a Novel Biomarker for Keloid. ---
14  2022 Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. DpC, NDRG1, PC, PSCs, TGF
15  2022 Tenascin-C can Serve as an Indicator for the Immunosuppressive Microenvironment of Diffuse Low-Grade Gliomas. CGGA, LGGs
16  2022 Tenascin-C promotes bladder cancer progression and its action depends on syndecan-4 and involves NF-κB signaling activation. BCa, ECM, LSCM
17  2022 Tenascin-C restricts reactive astrogliosis in the ischemic brain. ICAM-1
18  2022 Tenascins Interfere With Remyelination in an Ex Vivo Cerebellar Explant Model of Demyelination. ECM, OPCs, TN-R
19  2022 The expression and role of tenascin C in abdominal aortic aneurysm formation and progression. AAA, VSMC, WT
20  2022 The extracellular matrix molecule tenascin-C modulates cell cycle progression and motility of adult neural stem/progenitor cells from the subependymal zone. aNSPCs, CNS, ECM, EGF, LN-1, PDL, SEZ, SGZ
21  2021 Chondrocyte protein co-synthesis network analysis links ECM mechanosensing to metabolic adaptation in osteoarthritis. COL11A1, COMP, ECM, OA
22  2021 Comparison of preoperative serum neopterin, periostin, indoleamine 2,3-dioxygenase, YKL-40, and tenascin-C levels with current tumor markers for early-stage endometrial cancer. CEA, IDO
23  2021 Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3. FXS, IL-6, KO
24  2021 Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma. DSG2, E-cad, FOXM1, MMP-9, MYO1B, OTSCC, PDPN, PLAU
25  2021 Detection of osteoarthritis in dogs by metabolic, pro-inflammatory and degenerative synovial fluid biomarkers and traditional radiographic screening: A pilot study. IL-1beta, MMP-2, OA, SF, TNF-alpha
26  2021 Different Functions of Recombinantly Expressed Domains of Tenascin-C in Glial Scar Formation. SCI
27  2021 Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration. CFs, iCMs, MSNs
28  2021 Elevated glucose alters global gene expression and tenascin-C alternative splicing in mesangial cells. ECM, FN
29  2021 Elevated Serum Tenascin-C Predicts Mortality in Critically Ill Patients With Multiple Organ Dysfunction. APACHE II, SAPS II, SOFA
30  2021 Endometrial gene expression profiling of recurrent implantation failure after in vitro fertilization. ddPCR, FOXP3, IVF, KEGG, MME, PANOGA, RIF, WWC1
31  2021 Evaluation of the Effect of Hyaluronic Acid-Based Biomaterial Enriched With Tenascin-C on the Behavior of the Neural Stem Cells. HA, NSCs
32  2021 Exosomes from COVID-19 Patients Carry Tenascin-C and Fibrinogen-beta in Triggering Inflammatory Signals in Cells of Distant Organ. FGB, IL-6, NF-kappaB, TNF-alpha
33  2021 Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. CAF, CRC
34  2021 Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial. AF, BGN, EDN1, PREDICT-AF, THBS2
35  2021 Extracellular Vesicles: An Emerging Mechanism Governing the Secretion and Biological Roles of Tenascin-C. ECM, EVs, FN
36  2021 Fibroblast Growth Factor 2 Augments Transforming Growth Factor Beta 1 Induced Epithelial-mesenchymal Transition in Lung Cell Culture Model. ACTA2, EMT, FGF-2, FN, TGF-beta1
37  2021 Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C. ---
38  2021 Human Cerebral Cortex Proteome of Fragile X-Associated Tremor/Ataxia Syndrome. CD38, CNS, FMR1, FXTAS, PSAT1
39  2021 Immunohistochemical Comparative Study of Aggressive and Non-aggressive Central Giant Cell Lesions of the Jaws Based on the Tenascin-C Expression Profile. CGCLs, MGC, MVC
40  2021 Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy. ---
41  2021 Impact of Tenascin-C on Radiotherapy in a Novel Syngeneic Oral Squamous Cell Carcinoma Model With Spontaneous Dissemination to the Lymph Nodes. OSCC, TIL, TME
42  2021 Increased Tenascin C, Osteopontin and HSP90 Levels in Plasmatic Small Extracellular Vesicles of Pediatric ALK-Positive Anaplastic Large Cell Lymphoma: New Prognostic Biomarkers? ALCL, ALK, HDs, HSP90AA1, KEGG, NPM, PI3K, sEVs
43  2021 Influence of microcurrent on the modulation of remodelling genes in a wound healing assay. CTGF, FMOD, IGF1, MC, Scx, TGFB
44  2021 Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression. ---
45  2021 Knock-Out of Tenascin-C Ameliorates Ischemia-Induced Rod-Photoreceptor Degeneration and Retinal Dysfunction. ECM, ERG, I/R, KO, VGLUT1, WT
46  2021 Latent TGF-beta Activation Is a Hallmark of the Tenascin Family. EMT, FBG, LAP, TGF-beta, TN-R, TN-W, TNX
47  2021 Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker. ECM, GEO, TMA, TN, TNX
48  2021 Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-kappaB/miR-155-5p inflammatory loop. CTGF, DKD, ELISA, FN, GFR, RMCs, T2DM, TLR4, UACR
49  2021 MicroRNA‑218 inhibits the malignant phenotypes of glioma by modulating the TNC/AKT/AP‑1/TGFβ1 feedback signaling loop. TGF-beta1
50  2021 Noggin Overexpression Impairs the Development of Muscles, Tendons, and Aponeurosis in Soft Palates by Disrupting BMP-Smad and Shh-Gli1 Signaling. BMP, HPP, LVP, PLP, TVP
51  2021 Novel Human Tenascin-C Function-Blocking Camel Single Domain Nanobodies. ECM, hTNC
52  2021 Potential major depressive disorder biomarkers in pediatric population - a pilot study. MDD, PRDX1
53  2021 Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma. COX-2, LVSI, Rad-score
54  2021 Prostate tumor-induced stromal reprogramming generates Tenascin C that promotes prostate cancer metastasis through YAP/TAZ inhibition. BMP4, CM, ECs, PCa
55  2021 Proteomic Analysis Reveals Key Proteins in Extracellular Vesicles Cargo Associated with Idiopathic Pulmonary Fibrosis In Vitro. ECM, EVs, FBN1, IGFBP7, IPF, LOXL1
56  2021 Relationships Between Circulating Tenascin-C Levels and Gonadal Hormones in Male Patients with Depressive Disorder: A Retrospective, Cross-Sectional Study. TSH
57  2021 Serum tenascin-C predicts resistance to steroid combination therapy in high-risk Kawasaki disease: a multicenter prospective cohort study. CALs, IVIG, KD
58  2021 Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritis. CCP, cit-TNC, RA
59  2021 Systemic Proteomic Analysis Reveals Distinct Exosomal Protein Profiles in Rheumatoid Arthritis. AGT, COMP, LBP, RA, TTR
60  2021 Tenascin C Has a Modest Protective Effect on Acute Lung Pathology during Methicillin-Resistant Staphylococcus aureus-Induced Pneumonia in Mice. MRSA
61  2021 Tenascin C Promotes Glioma Cell Malignant Behavior and Inhibits Chemosensitivity to Paclitaxel via Activation of the PI3K/AKT Signaling Pathway. ---
62  2021 Tenascin-C Deficiency Is Associated With Reduced Bacterial Outgrowth During Klebsiella pneumoniae-Evoked Pneumosepsis in Mice. ---
63  2021 Tenascin-C in Heart Diseases-The Role of Inflammation. ECM
64  2021 Tenascin-C induction exacerbates post-stroke brain damage. ---
65  2021 Tenascin-c knockdown suppresses vasculogenic mimicry of gastric cancer by inhibiting ERK- triggered EMT. VM
66  2021 Tenascin-C Participates Pulmonary Injury Induced by Paraquat Through Regulating TLR4 and TGF-β Signaling Pathways. PQ
67  2021 Tenascin-C promotes epithelial-to-mesenchymal transition and the mTOR signaling pathway in nasopharyngeal carcinoma. EMT, NPC
68  2021 Tenascin-C regulates migration of SOX10 tendon stem cells via integrin-α9 for promoting patellar tendon remodeling. DEGs, integrin-alpha9
69  2021 Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis. AS, ECM, FSP1, scRNA-seq
70  2021 Tenascin-C: Friend or Foe in Lung Aging? ECM, HTV, WT
71  2021 The expression of tenascin-C in neural stem/progenitor cells is stimulated by the growth factors EGF and FGF-2, but not by TGFβ1. ECM, EGF, FGF, NSPCs, TGF
72  2021 The Extracellular Matrix Glycoprotein Tenascin C and Adult Neurogenesis. CNS, ECM
73  2021 The long non-coding RNA ET-20 mediates EMT by impairing desmosomes in breast cancer cells. EMT, lncRNAs
74  2021 The neuroprotective function of 2-carba-cyclic phosphatidic acid: Implications for tenascin-C via astrocytes in traumatic brain injury. 2ccPA, TBI
75  2021 The Role of Tenascin C in Cardiac Reverse Remodeling Following Banding-Debanding of the Ascending Aorta. alpha-SMA, COL1, HCFs, LV, TN-C KO, WT
76  2021 The role of Tenascin-C in HIV associated pre-eclampsia. PE
77  2021 The Role of Tenascin-C in Tissue Injury and Repair After Stroke. SAH
78  2021 The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma. IDO, MPM
79  2020 Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. GBM
80  2020 Assessment of serum tenascin-C and growth differentiation factor-15 among type 2 diabetes mellitus patients with and without acute coronary syndrome. ACS, CK-MB, CK-T, GDF15, T2DM
81  2020 Characterization of Bone Marrow and Wharton's Jelly Mesenchymal Stromal Cells Response on Multilayer Braided Silk and Silk/PLCL Scaffolds for Ligament Tissue Engineering. BM-MSCs, Col I, Col III, PLCL, WJ-MSCs
82  2020 Delta9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. Delta9-THCA, DIO, HFD, NAFLD
83  2020 Dose-Response Tendon-Specific Markers Induction by Growth Differentiation Factor-5 in Human Bone Marrow and Umbilical Cord Mesenchymal Stem Cells. COL1A1, DCN, hGDF-5, SCX-A, TNMD
84  2020 Down-regulation of tenascin-C inhibits breast cancer cells development by cell growth, migration, and adhesion impairment. ECM, EMT
85  2020 ECM deposition is driven by caveolin-1-dependent regulation of exosomal biogenesis and cargo sorting. Cav-1, ECM, MVBs
86  2020 Effects of Tenascin C on the Integrity of Extracellular Matrix and Skin Aging. ECM, TGF-beta1, TNC-L
87  2020 Elevated Tenascin-C Serum Levels in Patients With Axial Spondyloarthritis. axSpA, BASDAI, CRP, HS
88  2020 Enhanced Growth of Lapine Anterior Cruciate Ligament-Derived Fibroblasts on Scaffolds Embroidered from Poly(l-lactide-co-epsilon-caprolactone) and Polylactic Acid Threads Functionalized by Fluorination and Hexamethylene Diisocyanate Cross-Linked Collagen Foams. ACLs, DCN, EDC, HMDI, q-PCR, sGAG, TNMD
89  2020 Enhanced tendon restoration effects of anti-inflammatory, lactoferrin-immobilized, heparin-polymeric nanoparticles in an Achilles tendinitis rat model. COX-2, DCN, IL-1beta, MMP-3, TNF-alpha
90  2020 Eosinophil accumulation in postnatal lung is specific to the primary septation phase of development. ECM
91  2020 Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance. HF, HT, PVR, RVEDD
92  2020 Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties. CP, Na, PDAC
93  2020 Foxo3a aggravates inflammation and induces apoptosis in IL-1-treated rabbit chondrocytes via positively regulating tenascin-c. OA
94  2020 Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies. TNW
95  2020 IL-33/ST2 axis promotes glioblastoma cell invasion by accumulating tenascin-C. IL-33, NF-kappaB
96  2020 Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide. ECM, MMPs, pFN, TME
97  2020 Loss of the Extracellular Matrix Molecule Tenascin-C Leads to Absence of Reactive Gliosis and Promotes Anti-inflammatory Cytokine Expression in an Autoimmune Glaucoma Mouse Model. CO, EAG, ECM, IOP, ONA, RGCs
98  2020 Myofiber necroptosis promotes muscle stem cell proliferation via releasing Tenascin-C during regeneration. EGFR, MLKL, MuSC, RIPK1
99  2020 Patients with enthesitis related arthritis show similar monocyte function pattern as seen in adult axial spondyloarthropathy. ERA, HC, LPS, MRP, PG, SFMC, TLR, WB
100  2020 Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy. HRECs, IL-13, IPR, OIR, PDR, PN